David R Riley (David Riley)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Systemic Lupus Erythematosus

Optical Coherence Tomography

Diabetic Retinopathy

Cardiovascular Disease

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Diabetes, metabolic syndrome and obesity : targets and therapy

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

David R Riley, Theresa J Hydes, Gema Hernadez, Sizheng S Zhao, Uazman Alam, Daniel J Cuthbertson
The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes. Liver international : official journal of the International Association for the Study of the Liver (2024)
Alex E Henney, David R Riley, Theresa J Hydes, Matthew Anson, Gema H Ibarburu, Sizheng S Zhao, Daniel J Cuthbertson, Uazman Alam
Metabolic syndrome traits differentially and cumulatively influence micro- and macrovascular disease risk in patients with MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Aikaterini Eleftheriadou, David R Riley, Sizheng Steven Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia (2024)
Aikaterini Eleftheriadou, David R Riley, Sizheng Steven Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia 67 (7) (2024)
Aikaterini Eleftheriadou, David R Riley, Sizheng Steven Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia 67 (7) (2024)
Aikaterini Eleftheriadou, David R Riley, Sizheng Steven Zhao, Philip Austin, Gema Hernández, Gregory Y H Lip, Timothy L Jackson, John P H Wilding, Uazman Alam
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database. Diabetologia 67 (7) (2024)
David R Riley, Hani Essa, Philip Austin, Frank Preston, Isatu Kargbo, Gema Hernández Ibarburu, Ramandeep Ghuman, Daniel J Cuthbertson, Gregory Yoke Hong Lip, Uazman Alam
All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes. Diabetes, obesity & metabolism (2023)
Frank George Preston, David R Riley, Shazli Azmi, Uazman Alam
Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)